CRISPR QC
PrivateLast Round
Series A
Jan 5, 2024
Total Funding Raised
$11.6M
Company Overview
CRISPR QC is a biotechnology company that provides an analytics platform to simulate and analyze the gene editing process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Sensors
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CRISPR QC Comparables
Compare CRISPR QC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| COBO Technologies | 87% | |
| Countagen AB | 81% | |
| Paragraf | 78% |
CRISPR QC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 5, 2024 | ||||
| Seed | Jan 9, 2023 | ||||
| Accelerator | Aug 12, 2022 |
CRISPR QC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serra Ventures | Seed |
| EvoNexus | Accelerator |
| Xcellerant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2024
$10M round led by Xcellerant Ventures.
- Jan 9, 2023
$1.6M round led by Serra Ventures
CRISPR QC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CRISPR QC's valuation, stock price, and market status.
Is CRISPR QC a public or private company?
CRISPR QC is a private company.
What is the current stock price of CRISPR QC?
CRISPR QC is a private company with no public stock price. No recent secondary market data is available.
How much is CRISPR QC worth (valuation)?
Valuation information for CRISPR QC is not publicly available.
Can I buy CRISPR QC stock?
CRISPR QC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CRISPR QC's last funding round?
CRISPR QC's most recent funding round was Series A on January 5, 2024.
Who are the main investors in CRISPR QC?
Key investors in CRISPR QC include Serra Ventures, EvoNexus, Xcellerant Ventures.
Will CRISPR QC IPO soon?
No public IPO plans have been announced for CRISPR QC.
How can I track CRISPR QC secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CRISPR QC's secondary market activity and sign up for updates.